IMMP: Immutep Corp Company Value to Net Income

The market trend for Immutep Limited (IMMP) shown on this price chart demonstrates a value of -0.50. Immutep Limited leads the immunotherapy segment, utilizing proprietary cell activation methods to combat tumors. The business relies on the creation of unique drugs that retrain the body's defense systems. The strategy is based on implementing new cancer treatment standards, and its independence from macroeconomic factors makes this sector a resilient defensive asset.

Price to Earnings Ratio: Immutep Limited ADR (IMMP) for 09/25/2023 - 11/10/2026

Comprehensive metric breakdowns and analytics for Immutep Limited ADR (IMMP)

- share price and expert price forecast:

Price Performance Chart immutep.com|IMMP - Consensus Target

- market capitalization information:

Market Value Immutep Limited|IMMP - Real Price to Acquire Entire Company

- balance sheet net asset value indicators:

Accounting Value per Share Immutep|IMMP - Company Book Value|Market-to-Book Ratio immutep.com|IMMP - Aggregate Company Assets

- debt obligations and liquidity statistics:

- company profitability and valuation multiples indicators:

IMMP - Company Net Income|Future Profit Immutep Limited|IMMP - Price to Earnings Ratio|Forward P/E Multiple Immutep Ltd|IMMP - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Immutep Limited|IMMP - Operating profit EBITDA|Net earnings per one share for the last twelve months Immutep|IMMP - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months immutep.com|IMMP - Net earnings per share growth this year|Expected earnings per share trend next year Immutep Limited

Comprehensive company analysis:immutep.com IMMP

Investors must distinguish fundamental business resilience from market noise when assessing asset value. The P/E ratio compares current market capitalization with actual earnings to determine the premium paid for future income. The P/E trajectory of Immutep Limited (IMMP) visualizes capital's real-time reaction to financial reports. For Immutep Limited (IMMP), this indicator reflects market optimism regarding their cutting-edge developments in LAG-3 immunotherapy.

Key competitors